Skip to content

Safety and Feasibility of the Use of the Dual Robotic Arm Accessory With the Levita Magnetic Surgical System in Laparoscopic Procedures

Prospective, Multi-center, Single-arm, Open Label Study Designed to Assess the Safety and Feasibility of the Use of the Dual Robotic Arm Accessory With the Levita Magnetic Surgical System in Laparoscopic Procedures

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05695989
Acronym
MARS GI
Enrollment
22
Registered
2023-01-25
Start date
2023-01-19
Completion date
2023-03-08
Last updated
2025-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bariatric Surgery Candidate, Cholelithiases, Other Disease

Brief summary

The purpose of this study is to evaluate the safety and feasibility of the Levita Dual Robotic Arm Accessory (DRAA) used with the Levita Magnetic Surgical System (MSS)

Detailed description

Prospective, multi-center, single-arm, open label study designed to assess the safety and feasibility of the use of the Dual Robotic Arm Accessory with the Levita Magnetic Surgical System in laparoscopic procedures

Interventions

DEVICEDual Robotic Arm Accessory (DRAA)

Dual Robotic Arm Accessory (DRAA)

Sponsors

The Cleveland Clinic
CollaboratorOTHER
Levita Magnetics
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* • Subject is at least 18 years of age * Subject is scheduled to undergo elective laparoscopic procedure * Subject signs a written Informed Consent Form (ICF) to participate in the study prior to any study required procedures

Exclusion criteria

* • Subjects with pacemakers, defibrillators, or other electromedical implants * Subjects with ferromagnetic implants * Subjects with significant comorbidities: cardiovascular, neuromuscular, chronic obstructive pulmonary disease, and urological disease (renal failure) * Subjects with a clinical history of impaired coagulation confirmed by abnormal blood tests * Subject has an anatomical abnormality or disease of intended target tissue noted after initiation of index procedure that would prevent device use * Subject is pregnant or wishes to become pregnant during the length of study participation * Subject is not likely to comply with the follow-up evaluation schedule * Subject is participating in a clinical trial of another investigational drug or device Prisoner or under incarceration

Design outcomes

Primary

MeasureTime frameDescription
Adverse Events- Safety30 daysAdverse events related to the device

Secondary

MeasureTime frameDescription
Rate That the Dual Robotic Arm Accessory (DRAA) is Able to Engage, Move, and Decouple With the Magnetic Surgical System as Controlled by the SurgeonSurgery timeRatio of successful attempts vs unsuccessful attempts
Conversion Rate to Open SurgerySurgery timeRatio of conversion from laparoscopic to open surgery due to inability of the robotic system to provide adequate visualization

Countries

Chile

Participant flow

Participants by arm

ArmCount
DRAA (Dual Robotic Arm Accessory)
Levita has developed a Robotic Platform (DRAA) to assist in external management of the controlling magnet and the laparoscopic camera, which would give better control of surgical tools to the surgeon.
20
Total20

Baseline characteristics

CharacteristicDRAA (Dual Robotic Arm Accessory)
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
2 Participants
Age, Categorical
Between 18 and 65 years
18 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
20 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
0 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
Region of Enrollment
Chile
20 participants
Sex: Female, Male
Female
10 Participants
Sex: Female, Male
Male
10 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 20
other
Total, other adverse events
12 / 20
serious
Total, serious adverse events
0 / 20

Outcome results

Primary

Adverse Events- Safety

Adverse events related to the device

Time frame: 30 days

ArmMeasureValue (NUMBER)
DRAA (Dual Robotic Arm Accessory)Adverse Events- Safety0 Device related adverse events
Secondary

Conversion Rate to Open Surgery

Ratio of conversion from laparoscopic to open surgery due to inability of the robotic system to provide adequate visualization

Time frame: Surgery time

ArmMeasureValue (NUMBER)
DRAA (Dual Robotic Arm Accessory)Conversion Rate to Open Surgery0 Converted procedures
Secondary

Rate That the Dual Robotic Arm Accessory (DRAA) is Able to Engage, Move, and Decouple With the Magnetic Surgical System as Controlled by the Surgeon

Ratio of successful attempts vs unsuccessful attempts

Time frame: Surgery time

ArmMeasureValue (NUMBER)
DRAA (Dual Robotic Arm Accessory)Rate That the Dual Robotic Arm Accessory (DRAA) is Able to Engage, Move, and Decouple With the Magnetic Surgical System as Controlled by the Surgeon20 Number Surgeries completed successfully

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026